Form 8-K - Current report:
SEC Accession No. 0001193125-24-272562
Filing Date
2024-12-06
Accepted
2024-12-06 17:20:53
Documents
13
Period of Report
2024-12-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d840460d8k.htm   iXBRL 8-K 51287
  Complete submission text file 0001193125-24-272562.txt   171398

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vtrs-20241206.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtrs-20241206_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtrs-20241206_pre.xml EX-101.PRE 10812
16 EXTRACTED XBRL INSTANCE DOCUMENT d840460d8k_htm.xml XML 3527
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

EIN.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39695 | Film No.: 241533247
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)